Kardon Adam, Murray Robert S, Khalid Mazhar, Colloca Luana, Simard J Marc, Badjatia Neeraj, Murthi Sarah B, Morris Nicholas A
Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA.
Program in Trauma, R Adams Cowley Shock Trauma Center, Baltimore, MD, USA.
Neurohospitalist. 2022 Jul;12(3):563-566. doi: 10.1177/19418744221099412. Epub 2022 May 12.
Debilitating headache persists after acute aneurysmal subarachnoid hemorrhage (SAH). Despite high prevalence, little is known regarding optimal treatment strategies for SAH-related headache. Nonpharmacologic adjunctive therapies are emerging as tools to help treat pain and limit opioid exposure in the hospital. Virtual reality (VR) is an immersive audiovisual experience that has been shown to reduce pain perception in other patient populations. The role of VR in acute brain injury is unknown. Here we report a patient with SAH who suffered from persistent headache during her hospitalization despite escalation of analgesic pharmacotherapy. A trial of VR was used as an adjunct to medication over four days. The patient reported subjective improvement in pain and anxiety. VR may provide additional analgesia and anxiolysis over pharmacologic measures alone and warrants further study in patients with acute brain injury.
急性动脉瘤性蛛网膜下腔出血（SAH）后，使人虚弱的头痛仍持续存在。尽管患病率很高，但对于SAH相关头痛的最佳治疗策略却知之甚少。非药物辅助治疗正逐渐成为帮助治疗疼痛和限制住院期间阿片类药物使用的手段。虚拟现实（VR）是一种沉浸式视听体验，已被证明可降低其他患者群体的疼痛感知。VR在急性脑损伤中的作用尚不清楚。在此，我们报告一名SAH患者，尽管镇痛药物治疗不断升级，但在住院期间仍遭受持续性头痛。在四天时间里，将VR试验用作药物治疗的辅助手段。患者报告疼痛和焦虑有主观改善。VR可能比单纯的药物治疗措施提供额外的镇痛和抗焦虑作用，值得在急性脑损伤患者中进一步研究。
